Report Detail
COVID-19 Impact on Global Gene Therapies for Cancer Treatment Market Size, Status and Forecast 2020-2026
- RnM3984852 |
- 03 June, 2020 |
- Global |
- 98 Pages |
- QYResearch |
- Other
In the medicine field, gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gene Therapies for Cancer Treatment market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Gene Therapies for Cancer Treatment industry.
Based on our recent survey, we have several different scenarios about the Gene Therapies for Cancer Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Gene Therapies for Cancer Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapies for Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapies for Cancer Treatment market in terms of revenue.
Players, stakeholders, and other participants in the global Gene Therapies for Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Gene Therapies for Cancer Treatment market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Gene Therapies for Cancer Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapies for Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapies for Cancer Treatment market.
The following players are covered in this report:
Takara Bio
Tocagen
VBL Therapeutics
Cold Genesys
Genprex
Momotaro-Gene
MultiVir
SynerGene Therapeutics
Ziopharm Oncology
Anchiano Therapeutics
Celgene
Celsion
Bluebird Bio
Gene Therapies for Cancer Treatment Breakdown Data by Type
Somatic Cell Gene Therapy (SCGT)
Germline Gene Therapy (GGT)
Gene Therapies for Cancer Treatment Breakdown Data by Application
Cancer Research Centers
Diagnostic Laboratories
Cancer Hospitals
Others
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Gene Therapies for Cancer Treatment Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Somatic Cell Gene Therapy (SCGT)
- 1.4.3 Germline Gene Therapy (GGT)
- 1.5 Market by Application
- 1.5.1 Global Gene Therapies for Cancer Treatment Market Share by Application: 2020 VS 2026
- 1.5.2 Cancer Research Centers
- 1.5.3 Diagnostic Laboratories
- 1.5.4 Cancer Hospitals
- 1.5.5 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Gene Therapies for Cancer Treatment Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Gene Therapies for Cancer Treatment Industry
- 1.6.1.1 Gene Therapies for Cancer Treatment Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Gene Therapies for Cancer Treatment Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Gene Therapies for Cancer Treatment Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Gene Therapies for Cancer Treatment Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Gene Therapies for Cancer Treatment Market Perspective (2015-2026)
- 2.2 Gene Therapies for Cancer Treatment Growth Trends by Regions
- 2.2.1 Gene Therapies for Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Gene Therapies for Cancer Treatment Historic Market Share by Regions (2015-2020)
- 2.2.3 Gene Therapies for Cancer Treatment Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Gene Therapies for Cancer Treatment Market Growth Strategy
- 2.3.6 Primary Interviews with Key Gene Therapies for Cancer Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Gene Therapies for Cancer Treatment Players by Market Size
- 3.1.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue (2015-2020)
- 3.1.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Gene Therapies for Cancer Treatment Market Concentration Ratio
- 3.2.1 Global Gene Therapies for Cancer Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Gene Therapies for Cancer Treatment Revenue in 2019
- 3.3 Gene Therapies for Cancer Treatment Key Players Head office and Area Served
- 3.4 Key Players Gene Therapies for Cancer Treatment Product Solution and Service
- 3.5 Date of Enter into Gene Therapies for Cancer Treatment Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Type (2015-2020)
- 4.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2021-2026)
5 Gene Therapies for Cancer Treatment Breakdown Data by Application (2015-2026)
- 5.1 Global Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
- 5.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Gene Therapies for Cancer Treatment Market Size (2015-2020)
- 6.2 Gene Therapies for Cancer Treatment Key Players in North America (2019-2020)
- 6.3 North America Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
- 6.4 North America Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Gene Therapies for Cancer Treatment Market Size (2015-2020)
- 7.2 Gene Therapies for Cancer Treatment Key Players in Europe (2019-2020)
- 7.3 Europe Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
- 7.4 Europe Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
8 China
- 8.1 China Gene Therapies for Cancer Treatment Market Size (2015-2020)
- 8.2 Gene Therapies for Cancer Treatment Key Players in China (2019-2020)
- 8.3 China Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
- 8.4 China Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Gene Therapies for Cancer Treatment Market Size (2015-2020)
- 9.2 Gene Therapies for Cancer Treatment Key Players in Japan (2019-2020)
- 9.3 Japan Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
- 9.4 Japan Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Gene Therapies for Cancer Treatment Market Size (2015-2020)
- 10.2 Gene Therapies for Cancer Treatment Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
- 10.4 Southeast Asia Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
11 India
- 11.1 India Gene Therapies for Cancer Treatment Market Size (2015-2020)
- 11.2 Gene Therapies for Cancer Treatment Key Players in India (2019-2020)
- 11.3 India Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
- 11.4 India Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Gene Therapies for Cancer Treatment Market Size (2015-2020)
- 12.2 Gene Therapies for Cancer Treatment Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
- 12.4 Central & South America Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Takara Bio
- 13.1.1 Takara Bio Company Details
- 13.1.2 Takara Bio Business Overview and Its Total Revenue
- 13.1.3 Takara Bio Gene Therapies for Cancer Treatment Introduction
- 13.1.4 Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2015-2020))
- 13.1.5 Takara Bio Recent Development
- 13.2 Tocagen
- 13.2.1 Tocagen Company Details
- 13.2.2 Tocagen Business Overview and Its Total Revenue
- 13.2.3 Tocagen Gene Therapies for Cancer Treatment Introduction
- 13.2.4 Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
- 13.2.5 Tocagen Recent Development
- 13.3 VBL Therapeutics
- 13.3.1 VBL Therapeutics Company Details
- 13.3.2 VBL Therapeutics Business Overview and Its Total Revenue
- 13.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Introduction
- 13.3.4 VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
- 13.3.5 VBL Therapeutics Recent Development
- 13.4 Cold Genesys
- 13.4.1 Cold Genesys Company Details
- 13.4.2 Cold Genesys Business Overview and Its Total Revenue
- 13.4.3 Cold Genesys Gene Therapies for Cancer Treatment Introduction
- 13.4.4 Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
- 13.4.5 Cold Genesys Recent Development
- 13.5 Genprex
- 13.5.1 Genprex Company Details
- 13.5.2 Genprex Business Overview and Its Total Revenue
- 13.5.3 Genprex Gene Therapies for Cancer Treatment Introduction
- 13.5.4 Genprex Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
- 13.5.5 Genprex Recent Development
- 13.6 Momotaro-Gene
- 13.6.1 Momotaro-Gene Company Details
- 13.6.2 Momotaro-Gene Business Overview and Its Total Revenue
- 13.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Introduction
- 13.6.4 Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
- 13.6.5 Momotaro-Gene Recent Development
- 13.7 MultiVir
- 13.7.1 MultiVir Company Details
- 13.7.2 MultiVir Business Overview and Its Total Revenue
- 13.7.3 MultiVir Gene Therapies for Cancer Treatment Introduction
- 13.7.4 MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
- 13.7.5 MultiVir Recent Development
- 13.8 SynerGene Therapeutics
- 13.8.1 SynerGene Therapeutics Company Details
- 13.8.2 SynerGene Therapeutics Business Overview and Its Total Revenue
- 13.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Introduction
- 13.8.4 SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
- 13.8.5 SynerGene Therapeutics Recent Development
- 13.9 Ziopharm Oncology
- 13.9.1 Ziopharm Oncology Company Details
- 13.9.2 Ziopharm Oncology Business Overview and Its Total Revenue
- 13.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Introduction
- 13.9.4 Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
- 13.9.5 Ziopharm Oncology Recent Development
- 13.10 Anchiano Therapeutics
- 13.10.1 Anchiano Therapeutics Company Details
- 13.10.2 Anchiano Therapeutics Business Overview and Its Total Revenue
- 13.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Introduction
- 13.10.4 Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
- 13.10.5 Anchiano Therapeutics Recent Development
- 13.11 Celgene
- 10.11.1 Celgene Company Details
- 10.11.2 Celgene Business Overview and Its Total Revenue
- 10.11.3 Celgene Gene Therapies for Cancer Treatment Introduction
- 10.11.4 Celgene Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
- 10.11.5 Celgene Recent Development
- 13.12 Celsion
- 10.12.1 Celsion Company Details
- 10.12.2 Celsion Business Overview and Its Total Revenue
- 10.12.3 Celsion Gene Therapies for Cancer Treatment Introduction
- 10.12.4 Celsion Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
- 10.12.5 Celsion Recent Development
- 13.13 Bluebird Bio
- 10.13.1 Bluebird Bio Company Details
- 10.13.2 Bluebird Bio Business Overview and Its Total Revenue
- 10.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Introduction
- 10.13.4 Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
- 10.13.5 Bluebird Bio Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Gene Therapies for Cancer Treatment. Industry analysis & Market Report on COVID-19 Impact on Global Gene Therapies for Cancer Treatment is a syndicated market report, published as COVID-19 Impact on Global Gene Therapies for Cancer Treatment Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Gene Therapies for Cancer Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
